This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Walter MJ, Shen D, Shao J, Ding L, White BS, Kandoth C et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia 2013; 27: 1275–1282.
Potter VR . Transplantable animal cancer, the primary standard. Cancer Res 1961; 21: 1331–1333.
Nowell PC, Morris HP, Potter VP . Chromosomes of “minimal deviation” hepatomas and some other transplantable rat tumors. Cancer Res 1967; 27: 1565–1579.
Lichtman MA . Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases. Blood Cells Mol Dis 2000; 26: 572–581.
Lichtman MA . Does a diagnosis of myelogenous leukemia require 20 percent marrow myeloblasts and do less than 5 percent marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of “myelodysplasia”. Oncologist, (in press).
Killman SA . Preleukemia. Does it exist? Blood Cells 1976; 2: 81–96.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
Lichtman, M. Understanding the mutational evolution of clonal cytopenias and oligoblastic myelogenous leukemia (‘myelodysplasia’). Leukemia 28, 202 (2014). https://doi.org/10.1038/leu.2013.209
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.209